Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2.

Type 2 diabetes is characterized by abnormalities of insulin action in muscle, adipose tissue, and liver and by altered beta-cell function. To analyze the role of the insulin signaling pathway in these processes, we have generated mice with combined heterozygous null mutations in insulin receptor (ir), insulin receptor substrate (irs-1), and/or irs-2. Diabetes developed in 40% of ir/irs-1/irs-2(+/-), 20% of ir/irs-1(+/-), 17% of ir/irs-2(+/-), and 5% of ir(+/-) mice. Although combined heterozygosity for ir/irs-1(+/-) and ir/irs-2(+/-) results in a similar number of diabetic mice, there are significant differences in the underlying metabolic abnormalities. ir/irs-1(+/-) mice develop severe insulin resistance in skeletal muscle and liver, with compensatory beta-cell hyperplasia. In contrast, ir/irs-2(+/-) mice develop severe insulin resistance in liver, mild insulin resistance in skeletal muscle, and modest beta-cell hyperplasia. Triple heterozygotes develop severe insulin resistance in skeletal muscle and liver and marked beta-cell hyperplasia. These data indicate tissue-specific differences in the roles of IRSs to mediate insulin action, with irs-1 playing a prominent role in skeletal muscle and irs-2 in liver. They also provide a practical demonstration of the polygenic and genetically heterogeneous interactions underlying the inheritance of type 2 diabetes.

[1]  Y. Kido,et al.  Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue , 1998, Nature Genetics.

[2]  J. Sturis,et al.  Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. , 1996, The New England journal of medicine.

[3]  T. Hansen,et al.  Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus , 1993, The Lancet.

[4]  Simeon I. Taylor,et al.  Deconstructing Type 2 Diabetes , 1999, Cell.

[5]  D. Accili,et al.  Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. , 1997, Developmental biology.

[6]  D. Accili,et al.  Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. , 1994, The Journal of clinical endocrinology and metabolism.

[7]  T. Yagi,et al.  Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 , 1994, Nature.

[8]  William Arbuthnot Sir Lane,et al.  Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.

[9]  C. Kahn,et al.  Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein , 1991, Nature.

[10]  G. Lienhard,et al.  Insulin Receptor Substrate 3 Is Not Essential for Growth or Glucose Homeostasis* , 1999, The Journal of Biological Chemistry.

[11]  G. Lienhard,et al.  A Novel 160-kDa Phosphotyrosine Protein in Insulin-treated Embryonic Kidney Cells Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.

[12]  A. Godwin,et al.  A Grb2-associated docking protein in EGF- and insulin-receptor signalling , 1996, Nature.

[13]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[14]  D. Accili,et al.  The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. , 1999, The Journal of clinical investigation.

[15]  M. White,et al.  Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling , 1999, Nature Genetics.

[16]  D. Accili,et al.  Evidence That IRS-2 Phosphorylation Is Required for Insulin Action in Hepatocytes* , 1998, The Journal of Biological Chemistry.

[17]  F. Collins,et al.  The geneticist's approach to complex disease. , 1996, Annual review of medicine.

[18]  C. Kahn,et al.  Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.

[19]  Kahn Cr.  New concepts in the pathogenesis of diabetes mellitus. , 1996 .

[20]  E. Lander,et al.  Genetic dissection of complex traits science , 1994 .

[21]  C. Kahn,et al.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.

[22]  N. Sonenberg,et al.  Insulin signalling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice , 1996, Molecular and cellular biology.

[23]  C. Kahn,et al.  Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells , 1997, Molecular and cellular biology.

[24]  C. R. Kahn,et al.  Genetics of non-insulin-dependent (type-II) diabetes mellitus. , 1996, Annual review of medicine.

[25]  P. Parsons.  The study of quantitative traits , 1983 .

[26]  A. Cherrington,et al.  Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. , 1999, Diabetes.

[27]  G. Lienhard,et al.  The 60-kDa Phosphotyrosine Protein in Insulin-treated Adipocytes Is a New Member of the Insulin Receptor Substrate Family* , 1997, The Journal of Biological Chemistry.

[28]  J. Witte,et al.  Genetic dissection of complex traits , 1996, Nature Genetics.

[29]  G. Shulman,et al.  Disruption of IRS-2 causes type 2 diabetes in mice , 1998, Nature.

[30]  O. Pedersen,et al.  A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies. , 1996, The Journal of clinical investigation.

[31]  D. Accili,et al.  Expression of variant forms of insulin receptor substrate-1 identified in patients with noninsulin-dependent diabetes mellitus. , 1997, The Journal of clinical endocrinology and metabolism.

[32]  C. R. Kahn.  New concepts in the pathogenesis of diabetes mellitus. , 1996, Advances in internal medicine.

[33]  C. Kahn,et al.  Development of a Novel Polygenic Model of NIDDM in Mice Heterozygous for IR and IRS-1 Null Alleles , 1997, Cell.

[34]  R. Kulkarni,et al.  Liver-specific insulin receptor knockout mice are severely insulin resistant , 1999 .

[35]  D. Accili,et al.  Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. , 1997, The Journal of clinical investigation.

[36]  C. Kahn,et al.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. , 1998, Molecular cell.

[37]  N. Schork,et al.  Genetic Analysis of NIDDM: The Study of Quantitative Traits , 1996, Diabetes.

[38]  Mark D. Johnson,et al.  Early neonatal death in mice homozygous for a null allele of the insulin receptor gene , 1996, Nature Genetics.